Blockchain Startup Mediconnect Hires Patrick Curry As Adviser

Job Appointments | March 29, 2019 By:

Blockchain healthcare startup MediConnect has announced that Patrick Curry OBE has joined the company as an adviser to the board.

MediConnect is a blockchain solution designed to track medication all the way through the supply chain from the point at which it is manufactured to its prescription by medical professionals and purchase by patients. At a time when 200,000 Brits are said to be chronic users of prescription painkillers, MediConnect provides a blockchain solution to share information securely between companies, pharmacies, hospitals and health organisations.

Awarded an OBE by HM The Queen for services to international collaboration, Curry has over twenty years’ experience of developing policies and standards. He is the CEO of the British Business Federation Authority (BBFA), a governance body seeking to build collaborative, digital trust mechanisms across industries, and co-authored the UK government’s Lord Holmes Report in 2018: “Distributed Ledger Technologies for Public Good: Leadership, Collaboration and Innovation”. At BBFA, Patrick is tasked with overseeing working groups to implement the findings of this report, namely working collaboratively to implement new secure, private technologies, such as blockchains. This includes the Prescription Drug Addiction Working Group, which has signed up MediConnect as a member and invited contributions from all the major regulators.

“We are delighted to receive the support of such an influential and well-connected adviser as Patrick,” said Dexter Blackstock, CEO of MediConnect. “As head of the BBFA, Patrick specialises in seeing the value of technologies that can work between companies, industry bodies and governments. His support of MediConnect is therefore a highly significant endorsement of our solution and will help us onboard even more pharmacies and prescribers. By centrally tracing the medical supply chain and preventing the oversubscription of prescription drugs, MediConnect will protect the health of patients and save the NHS millions of pounds.”

Curry said that MediConnect is an excellent example of a solution designed to tackle a problem by bringing industry, government and regulatory bodies together.

“The overuse of prescription medication is a growing and worrying trend in society and the need for controlled and trusted information sharing across the medical sector is key to addressing this,” Curry said. Because MediConnect is focused on drug delivery to patients and not just on patient records, I see ground-breaking opportunities for significant wider benefits in mental health, unemployment, care for the elderly, other addictions including food, alcohol and gambling, as well as reductions in costs and risks across the health and pharmaceutical industries. I look forward to working with the MediConnect consortia to develop its blockchain-based solution to this very important, national, real-world problem.”